Neuroectodermal Tumors, Primitive
"Neuroectodermal Tumors, Primitive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of malignant tumors of the nervous system that feature primitive cells with elements of neuronal and/or glial differentiation. Use of this term is limited by some authors to central nervous system tumors and others include neoplasms of similar origin which arise extracranially (i.e., NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL). This term is also occasionally used as a synonym for MEDULLOBLASTOMA. In general, these tumors arise in the first decade of life and tend to be highly malignant. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2059)
Descriptor ID |
D018242
|
MeSH Number(s) |
C04.557.465.625.600.590 C04.557.470.670.590 C04.557.580.625.600.590
|
Concept/Terms |
Neuroectodermal Tumors, Primitive- Neuroectodermal Tumors, Primitive
- Neuroectodermal Tumor, Primitive
- Primitive Neuroectodermal Tumor
- Primitive Neuroectodermal Tumors
- Tumor, Primitive Neuroectodermal
- Tumors, Primitive Neuroectodermal
- Primitive Neuroepithelial Neoplasms
- Neuroepithelial Tumors, Primitive
- Neuroepithelial Tumor, Primitive
- Primitive Neuroepithelial Tumor
- Primitive Neuroepithelial Tumors
- Tumor, Primitive Neuroepithelial
- Tumors, Primitive Neuroepithelial
- PNET
- PNETs
- Neoplasms, Primitive Neuroepithelial
- Neoplasm, Primitive Neuroepithelial
- Neuroepithelial Neoplasm, Primitive
- Primitive Neuroepithelial Neoplasm
- Neuroepithelial Neoplasms, Primitive
|
Below are MeSH descriptors whose meaning is more general than "Neuroectodermal Tumors, Primitive".
Below are MeSH descriptors whose meaning is more specific than "Neuroectodermal Tumors, Primitive".
This graph shows the total number of publications written about "Neuroectodermal Tumors, Primitive" by people in this website by year, and whether "Neuroectodermal Tumors, Primitive" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 1 | 4 |
1996 | 4 | 0 | 4 |
1997 | 6 | 1 | 7 |
1998 | 2 | 1 | 3 |
1999 | 4 | 2 | 6 |
2000 | 4 | 2 | 6 |
2001 | 2 | 0 | 2 |
2002 | 0 | 2 | 2 |
2003 | 3 | 3 | 6 |
2004 | 3 | 1 | 4 |
2005 | 5 | 0 | 5 |
2006 | 2 | 0 | 2 |
2007 | 4 | 0 | 4 |
2008 | 6 | 0 | 6 |
2009 | 5 | 2 | 7 |
2010 | 4 | 1 | 5 |
2011 | 2 | 2 | 4 |
2012 | 2 | 2 | 4 |
2013 | 2 | 0 | 2 |
2014 | 4 | 0 | 4 |
2015 | 2 | 0 | 2 |
2016 | 1 | 0 | 1 |
2018 | 2 | 1 | 3 |
2019 | 3 | 0 | 3 |
2020 | 1 | 0 | 1 |
2021 | 2 | 0 | 2 |
2022 | 6 | 0 | 6 |
2023 | 2 | 0 | 2 |
2024 | 1 | 0 | 1 |
Below are the most recent publications written about "Neuroectodermal Tumors, Primitive" by people in Profiles.
-
Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors. Br J Cancer. 2024 Apr; 130(7):1096-1108.
-
Breastfeeding and risk of childhood brain tumors: a report from the Childhood Cancer and Leukemia International Consortium. Cancer Causes Control. 2023 Nov; 34(11):1005-1015.
-
Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours - A systematic review and meta-analysis. Eur J Cancer. 2023 03; 182:43-52.
-
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. Acta Neuropathol. 2023 01; 145(1):49-69.
-
Malignant teratoid intraocular ciliary body medulloepithelioma in a 5-year-old male with corresponding somatic copy number alteration profile of aqueous humor cell-free DNA. Ophthalmic Genet. 2022 12; 43(6):855-861.
-
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161. Invest New Drugs. 2022 12; 40(6):1306-1314.
-
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials. Acta Neuropathol. 2022 10; 144(4):733-746.
-
Spectrum of paired-like homeobox 2b immunoexpression in pediatric brain tumors with embryonal morphology. Pathol Int. 2022 Aug; 72(8):402-410.
-
Everolimus with or without bevacizumab in advanced pNET: CALGB 80701 (Alliance). Endocr Relat Cancer. 2022 05 09; 29(6):335-344.
-
Generalized methodology for radiomic feature selection and modeling in predicting clinical outcomes. Phys Med Biol. 2021 10 22; 66(21).